We attribute recurrent-specific markers such as ITGA5 as likely to target tumor subpopulations that are responsible for tumor metastatic programs, angiogenic features, and those that are prone to exhibit therapy evasion with increased self-renewal capacities as identified in our in vitro self-renewal assays [46]. Here, ITGA5 is linked to neoplasm.